News

Filter

Current filters:

ActavisDermatologicals

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

FTC puts conditions on Valeant’s acquisition of Precision Dermatology

FTC puts conditions on Valeant’s acquisition of Precision Dermatology

04-07-2014

Canada’s Valeant Pharmaceuticals International and its takeover target Precision Dermatology have agreed…

ActavisDermatologicalsMatawan PharmaceuticalsMergers & AcquisitionsPharmaceuticalPreCision DermatologyRegulationValeant Pharmaceuticals International

Back to top